New chief takes helm at BIO Ventures for Global Health; ProFibrix highlights PhII data;

 @FierceBiotech: Perceptive Informatics survey focuses on role of imaging in clinical trials. News | Follow @FierceBiotech

 @JohnCFierce: Analysts inevitably buzzing about the next big hep C buyout. Story | Follow @JohnCFierce

 @RyanMFierce: NYT essay on overuse of word #cancer in medicine. "The word "cancer" is so powerful it overwhelms any conversation." Report | Follow @RyanMFierce

 @MaureenFierce: Combo vaccines more convenient for children and parents, but might be costing doctors money. Item | Follow@MaureenFierce

> Melinda Moree says she will be moving on from her post as CEO of the nonprofit BIO Ventures for Global Health. Don Joseph, the COO, will take the helm. Story

> The Dutch biotech ProFibrix B.V. says its Phase II clinical trial with Fibrocaps in liver resection surgery resulted in a "highly statistically significant 50 percent reduction in mean time to hemostasis compared to active control." Release

> Boston-based Selecta Biosciences, a 2011 Fierce 15 winner, has kicked off a Phase I trial of nicotine vaccine SEL-068 for smoking cessation and relapse prevention. Report

Pharma News

 @FiercePharma: Forget DTC ads. Pfizer's going for direct-to-consumer sales: Lipitor from $PFE to people at generic price - WSJStory|  Follow @FiercePharma

> FDA warns Mylan on PR plant violations. Report

> Supercommittee's failure is pharma's gain, for now. News

> Ireland's exports set to fall off the patent cliff. Story

> Pfizer plans direct-to-consumer Lipitor sales. Item

 

Biotech Research News

> Treatment for aggressive form of prostate cancer may be on horizon. Item

> Two old drugs eyed as new brain tumor treatment. News

> AvidBiotics' protein treatment could fight food-borne bacteria, study shows. Story

> Novartis to test malaria drug in 2012 that could defeat the virus more quickly. Report

> Discovery: Sugar plus two drugs may equal cancer cell suicide. Article

Manufacturing News

> Counterculture drugmaker spoofs Big Pharma. News

> Compounder questions KV's Makena purity claim. Item

> Ben Venue shutdown strains J&J drug supply. Report

> Thanks for a miracle in Congress. Story

> Bill cites fakes dangers, ups penalties. Article

> J&J yields to activists on baby-product chemicals. News

And Finally... A group of investigators at New York University School of Medicine identified a set of biomarkers that presaged declining lung capacity among those exposed to dust from the collapse of the World Trade Center. Story 

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.